Skip to main content
main-content

Type 2 diabetes

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Featured podcast episode

ADA 2020 goes virtual!

Editorial Board Highlights

Listen to our Editorial Board reflecting on their highlights from the ADA scientific sessions, with discussion on the VERTIS-CV trial, diets for diabetes, insulin icodec and more (34:17).

ADA 2020

First weekly insulin shows equivalence with glargine in type 2 diabetes

Weekly calendar

A novel insulin that can be given as a once-weekly injection has achieved promising results in a randomized phase 2 trial involving people with type 2 diabetes.

ADA 2020

Icosapent ethyl lowers cardiovascular risk in people with diabetes

Heart and stethoscope

Icosapent ethyl reduces the risk for first and total cardiovascular events in statin-treated patients with diabetes, suggests a subgroup analysis of the REDUCE-IT trial.

medwireNews top story

‘Compelling evidence’ of greater diabetes treatment inertia for ethnic minorities

Mixed diabetes medications

Doctors are faster to initiate pharmacologic type 2 diabetes treatment in people from ethnic minorities than in White people but are then slower to intensify their treatment when needed, show data from the UK.

medwireNews top story

Cardiometabolic burden varies by age, sex, ethnicity at type 2 diabetes diagnosis

People in profile different age and nationalities

A study shows marked variations in cardiovascular risk burden according to age, sex, and ethnicity at the point of type 2 diabetes diagnosis, with implications for both diabetes prevention and cardiovascular risk management.

The continuing evolution of GLP-1RAs – webcast available now!

The continuing evolution of GLP-1RAs

Don’t miss out on this expert-led webcast on the continuing evolution of glucagon-like peptide-1 receptor agonists, chaired by Professor John Wilding.

medwireNews top story

Genetic markers of type 2 diabetes risk in East Asian people uncovered

DNA_multicoloured

A major genetic analysis sheds light on the similarities and differences in type 2 diabetes pathogenesis between people of East Asian and European origin.

Expert opinion editorial

Oral semaglutide: A technical triumph, with caveats

Balancing pros and cons

Diabetologist and Editorial Board member John Wilding gives his opinion on the latest addition to the GLP-1RA class, oral semaglutide [read more].

Get more on: Type 2 diabetes medications | GLP-1 receptor agonists

medwireNews top story

Prediabetes marks increased vascular risk

Cartoon of overweight man walking on a 'cardiovascular tightrope'

People who meet the criteria for prediabetes during the 3 years before a type 2 diabetes diagnosis have a higher burden of vascular disease than those who do not, research shows.

Podcast

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes?

Neil Skolnik

US primary care physician Neil Skolnik discusses the role of oral semaglutide in the care of people with type 2 diabetes and outlines key considerations for its use (12:26) [Listen now]

Get more on: Type 2 diabetes medications | GLP-1 receptor agonists

medwireNews top story

PIONEER 9, 10 confirm oral semaglutide efficacy in Japanese population

Man on weight scales

Results of the PIONEER 9 and 10 trials show that oral semaglutide is efficacious in Japanese people with type 2 diabetes.

medwireNews top story

Hypoglycemia risk with even mild renal dysfunction in real-world practice

Human kidney cross section on scientific background. 3d illustration

A large observational study reveals a strong link between reduced kidney function and increased incidence of hypoglycemia in adults with diabetes in routine clinical practice.

medwireNews top story

Preoperative metformin use associated with better outcomes after major surgery

Tablet device showing the chemical structure of Metformin

People with type 2 diabetes who are treated with metformin prior to undergoing major surgical interventions may have better postoperative outcomes than those without exposure to the drug, researchers report.

medwireNews top story

Exercise better than diet to combat early heart changes in type 2 diabetes

Older couple exercising in the park

The results of a small randomized trial suggest exercise is more helpful than diet for combating early cardiac dysfunction associated with type 2 diabetes, although both may be beneficial.

medwireNews top story

Cardioprotective benefits of dapagliflozin extend beyond people with diabetes

Heart failure

Treatment with dapagliflozin is associated with a significant reduction in the risk for heart failure worsening or cardiovascular death in people with heart failure and reduced ejection fraction regardless of whether or not they have diabetes, shows an exploratory analysis of DAPA-HF trial data.

medwireNews top story

Diabetes medication changes at hospital discharge of older adults often not beneficial

Doctor_hospital bed

Older adults with type 2 diabetes often receive diabetes medication adjustments at hospital discharge that may be of little or no benefit, study results suggest.

medwireNews top story

Liraglutide 3.0 mg boosts weight loss in insulin-dependent type 2 diabetes

Insulin pens

Adding liraglutide 3.0 mg to intensive behavioral therapy increases weight loss in overweight or obese people with insulin-treated type 2 diabetes, results of the phase 3 SCALE Insulin trial show.

medwireNews top story

Urgent action needed to improve dysglycemia screening in patients with heart disease

HbA1c

More than half of people with coronary artery disease have impaired glucose tolerance, yet many are unaware of this or are undertreated despite knowledge of their condition, results of the EUROASPIRE V survey show.

medwireNews top story

Diagnosis age enhances predictive power of family diabetes history

Portrait of three generations male family members together

The risk associated with a family history of type 2 diabetes is highest for people whose near relatives were diagnosed with the condition at a young age, show registry data.

medwireNews top story

‘Early therapeutic window’ highlighted for LADA

Open window

Optimal glycemic control during the first years after a latent autoimmune diabetes of adulthood diagnosis could prevent people’s microvascular complication risk from equaling that seen in those with type 2 diabetes, shows an analysis of the UKPDS.

06-24-2020 | ADA 2020 | Conference coverage | Article

ADA 2020 goes virtual! Editorial Board conference highlights

Listen to our Editorial Board reflecting on their ADA scientific highlights, and its novel virtual format (34:17).

05-06-2020 | Type 2 diabetes | Editorial | Article

Oral semaglutide: A technical triumph, with caveats

Diabetologist and Editorial Board member John Wilding gives his opinion on the latest addition to the GLP-1RA class, oral semaglutide.

04-29-2020 | Type 2 diabetes | Podcast | Article

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes?

US primary care physician Neil Skolnik discusses the role of oral semaglutide in the care of people with type 2 diabetes and outlines key considerations for its use (12:26).

Diagnosis and management of prediabetes: a consensus of GCC countries

Guidance based on outcomes of an advisory board of diabetes experts, for healthcare professionals addressing the diagnosis and treatment of prediabetes.

This interactive roadmap is intended for healthcare professionals practicing in Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. 

Funding for this roadmap was provided by Merck Serono Middle East FZ-LLC

Access the interactive roadmap

Downloadable slides

10-31-2018 | Slideset | Collection

FreeStyle Libre collection

These slide sets summarize the results of randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Image Credits